financetom
Business
financetom
/
Business
/
--Schlumberger Q2 Non-GAAP EPS $0.85 vs. $0.72 a Year Earlier; Revenue $9.14 Billion vs. $8.1 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Schlumberger Q2 Non-GAAP EPS $0.85 vs. $0.72 a Year Earlier; Revenue $9.14 Billion vs. $8.1 Billion
Jul 19, 2024 4:15 AM

06:59 AM EDT, 07/19/2024 (MT Newswires) --

Price: 49.73, Change: +1.01, Percent Change: +2.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 5, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Hudson Pacific Properties Q3 Adjusted Funds From Operations, Revenue Decrease
Hudson Pacific Properties Q3 Adjusted Funds From Operations, Revenue Decrease
Nov 5, 2025
09:24 AM EST, 11/05/2025 (MT Newswires) -- Hudson Pacific Properties ( HPP ) reported Q3 adjusted funds from operations Wednesday of $0.03 per diluted share, down from $0.11 a year earlier. Analysts polled by FactSet expected $0.02. Revenue for the quarter ended Sept. 30 was $186.6 million, down from $200.4 million a year earlier. Analysts surveyed by FactSet expected $184.3...
Perrigo begins strategic review of baby formula business
Perrigo begins strategic review of baby formula business
Nov 5, 2025
Nov 5 (Reuters) - Perrigo ( PRGO ) said on Wednesday it has initiated a strategic review of its infant formula business as the consumer health company shifts its focus to higher-margin branded products. The company is a top supplier of store-brand baby formula, which is sold under retailers' labels and can cost less than branded products. The infant formula...
Sionna Therapeutics' Q3 Net Loss Narrows
Sionna Therapeutics' Q3 Net Loss Narrows
Nov 5, 2025
09:24 AM EST, 11/05/2025 (MT Newswires) -- Sionna Therapeutics ( SION ) reported a Q3 net loss Wednesday of $0.46 per diluted share, narrower than a loss of $5.67 a year earlier. Weighted-average diluted shares outstanding totaled 44.3 million in the quarter ended Sept. 30, up from 4.5 million a year earlier. Two analysts polled by FactSet expected a loss...
Copyright 2023-2026 - www.financetom.com All Rights Reserved